The medical algorithmic audit
- PMID: 35396183
- DOI: 10.1016/S2589-7500(22)00003-6
The medical algorithmic audit
Erratum in
-
Correction to Lancet Digit Health 2022; 4: e384-97.Lancet Digit Health. 2022 Jun;4(6):e405. doi: 10.1016/S2589-7500(22)00089-9. Epub 2022 Apr 21. Lancet Digit Health. 2022. PMID: 35466080 No abstract available.
Abstract
Artificial intelligence systems for health care, like any other medical device, have the potential to fail. However, specific qualities of artificial intelligence systems, such as the tendency to learn spurious correlates in training data, poor generalisability to new deployment settings, and a paucity of reliable explainability mechanisms, mean they can yield unpredictable errors that might be entirely missed without proactive investigation. We propose a medical algorithmic audit framework that guides the auditor through a process of considering potential algorithmic errors in the context of a clinical task, mapping the components that might contribute to the occurrence of errors, and anticipating their potential consequences. We suggest several approaches for testing algorithmic errors, including exploratory error analysis, subgroup testing, and adversarial testing, and provide examples from our own work and previous studies. The medical algorithmic audit is a tool that can be used to better understand the weaknesses of an artificial intelligence system and put in place mechanisms to mitigate their impact. We propose that safety monitoring and medical algorithmic auditing should be a joint responsibility between users and developers, and encourage the use of feedback mechanisms between these groups to promote learning and maintain safe deployment of artificial intelligence systems.
Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests BG is a part-time employee of HeartFlow and Kheiron Medical Technologies and holds stock options with both as part of the standard compensation package. He was a part-time employee at Microsoft Research until May, 2021 and a scientific advisor for Kheiron Medical Technologies until September, 2021. All other authors declare no competing interests.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
